Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Apr 19, 2021)
Date Submitted: Jun 9, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Country-level Association of Socioeconomic, Environmental and Healthcare-Related Factors with the Disease-Burden and Mortality Rate of COVID-19
ABSTRACT
Background:
The COVID-19 pandemic is rapidly expanding throughout the world right now. Caused by a novel strain of the coronavirus, the manifestation of this pandemic is showing different level of disease-burden and mortality rate in different countries.
Objective:
In this paper, we investigated the effects of several socio-economic, environmental, and healthcare related factors on the disease burden and mortality rate of COIVID-19 across countries. Our experimental results provide a macro-level understanding of the most influential factors associated with the disease burden and mortality rate metrics.
Methods:
We developed a multiple-linear regression model using backward elimination to find the best fitting between reported death and cases across countries for country-level aggregated independent factors keeping COVID-19 test statistic in consideration.
Results:
Our results show that while the COVID-19 pandemic is seemed to be spreading more rapidly in economically affluent countries, it Is more deadly in countries with inadequate healthcare infrastructure, lower capacity of handling epidemics and lower allocation of healthcare budget.
Conclusions:
Taking the number of tests performed into account and normalizing the countries based on the cumulative distribution of cases across days, our analysis on the standardized factors provide both the direction and relative importance of different factors leading to several compelling insights to the most influential socio-economic and healthcare infrastructure-related factors from a country-level view. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.